ACESION PHARMA ApS: Financial statements 2020
CVR: 34083738
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -31,428,000 compared with DKK -41,223,161 the year before. Equity in the 2020 report amounted to DKK -20,048,000.
- Revenue
- DKK 0
- Profit/Loss
- DKK -31,428,000
- Equity
- DKK -20,048,000
- Total Assets
- DKK 64,533,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | - | -31.4 mio. | -20 mio. | - |
| 2019 | - | -35.8 mio. | -41.2 mio. | 524 t. | 7 |
| 2018 | - | -18.6 mio. | -25.1 mio. | -6.5 mio. | 10 |
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
| 2016 | - | -14.4 mio. | -18.3 mio. | 14.1 mio. | - |
Official annual report
How creditworthy is ACESION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 19, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ACESION PHARMA ApS.
As of October 19, 2020, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of ACESION PHARMA ApS.
As of June 30, 2020, Frans Gustaf Wuite has stepped down as adm. dir. of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -35,793,780, and the net result was DKK -41,223,161.
As of May 28, 2020, Jørgen Søberg Petersen has joined the board of directors of ACESION PHARMA ApS.
As of May 28, 2020, Ingelise Saunders has left the board of directors of ACESION PHARMA ApS.
As of May 28, 2020, Paul David Goldenheim has left the board of directors of ACESION PHARMA ApS.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.